Clinical Trial

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Study acronym: TNK-LVO
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A phase III, multicentre, prospective, randomised, open-label, blinded-endpoint clinical trial will evaluate two thrombolytic agents for the treatment of acute large vessel occlusion stroke within 4.5 hours from symptoms onset: intravenous tenecteplase bridging mechanical thrombectomy vs. intravenous alteplase bridging mechanical thrombectomy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-10-23; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2026-01-22
Trial Details
NCT Number NCT06658197
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect
Enrollment 850 participants
Start Date 2025-12-25
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-09